Dr. Melissa Webby of the University of Warwick has received a £2.2 million Wellcome Career Development Award to research the mechanisms that protect Gram-negative bacteria from antibiotics. This award ...
Dr. Melissa Webby of the University of Warwick has received a £2.2 million Wellcome Career Development Award to research the mechanisms that protect Gram-negative bacteria from antibiotics. This award ...
Dr. Melissa Webby of the University of Warwick has received a £2.2 million Wellcome Career Development Award to research the mechanisms that protect Gram-negative bacteria from antibiotics. This award ...
A new report highlights the need for better sediment management in Scotland’s hydropower systems to ensure both efficient energy production and ...
Dr. Melissa Webby of the University of Warwick has received a £2.2 million Wellcome Career Development Award to research the mechanisms that pro ...
Wienerberger has appointed Dagmar Steinert as its new CFO, effective March 1, 2025. She succeeds Gerhard Hanke, who will transition to the role o ...
SSAB has appointed Helena Norrman as its new EVP and Head of Group Communications, a role created within the Group Executive Committee. With her ...
(IN BRIEF) ABB has acquired Sensorfact BV, a leader in energy management solutions, to enhance its digital energy offerings for industrial clients. Sensorfact’s AI-powered SaaS platform helps small ...
A recent survey by ABN AMRO and Ajax reveals that nearly half of young women in the Netherlands have considered quitting sports, with psychologic ...
ABB has acquired Sensorfact BV, a leader in energy management solutions, to enhance its digital energy offerings for industrial clients. Sensorfa ...
Sanofi’s Sarclisa has been approved by the European Union as the first anti-CD38 therapy in combination with VRd to treat adult patients with newly diagnosed multiple myeloma who are ineligible for ...
Sanofi’s Sarclisa has been approved by the European Union as the first anti-CD38 therapy in combination with VRd to treat adult patients with newly diagnosed multiple myeloma who are ineligible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback